Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are These Steel And Biotech Stocks Deep In Red Today?

Page 1 of 2

There is strong market activity in the last full trading day ahead of the Christmas weekend. U.S. stocks are in green territory, with the Dow up by triple digits, spurred by an increase in oil prices. In this article, however, we’ll talk steel and biotechnology stocks to find out why United States Steel Corporation (NYSE:X), AK Steel Holding Corporation (NYSE:AKS), Great Basin Scientific Inc (NASDAQ:GBSN), Northwest Biotherapeutics, Inc (NASDAQ:NWBO) and Seres Therapeutics Inc (NASDAQ:MCRB) are trending lower today. In addition, we are going to assess the hedge fund sentiment towards these stocks.

In the eyes of most traders, hedge funds are assumed to be underperforming, old investment tools of the past. While there are more than 8,000 funds in operation at present, Insider Monkey looks at only the aristocrats of this group, around 730 funds. Contrary to popular belief, Insider Monkey’s research revealed that hedge funds underperformed in recent years because of their short positions as well as the huge fees that they charge, not because they are not good at picking stocks on the long side of their portfolios. Hedge funds did in fact manage to outperform the market on the long side of their portfolios. In fact, the 15 most popular small-cap stocks among hedge funds has returned 102% since the end of August 2012, beat the S&P 500 Index by 53 percentage points (see the details here).

United States Steel Corporation (NYSE:X) opened higher this morning, but has retracted since the bell. This comes after the company recently announced plans to delay the construction of an electric arc furnace at its Fairfield Works plant in Alabama. A mix of low steel prices and increased imports from abroad have prompted the management to halt their development plans until market conditions improve.

Follow United States Steel Corp (NYSE:X)
Trade (NYSE:X) Now!

Hedge fund affection for United States Steel Corporation (NYSE:X) cooled down a bit during the third quarter, with the number of funds invested in the company dropping to 25 from 29. Ken Griffin was among those scrambling for the exit, dumping 87% of his stake in the process. In its latest 13F filing, Citadel Investment Group reported ownership of 1.27 million shares valued at $13.2 million.

Another company affected by the slump in the steel market, AK Steel Holding Corporation (NYSE:AKS) shares are down by roughly 3% from yesterday’s closing price. The company’s board of directors has welcomed a new member according to a press release published yesterday. Gregory B. Kenny, who is currently serving as adviser to Michael McDonnell, the CEO of General Cable Corporation (NYSE:BGC), is set to assume his role on January 1, 2016, with AK Steel putting great value of his knowledge and experience in the manufacturing sector.

Follow Ak Steel Holding Corp (NYSE:AKS)
Trade (NYSE:AKS) Now!

At the end of the quarter, roughly 12.5% of AK Steel Holding Corporation (NYSE:AKS)’s common stock was held by 19 funds from our database, down from 20 a quarter earlier. Kenneth Tropin’s Graham Capital Management holds the largest stake in the company among the funds we follow: 14.5 million shares worth $10.3 million disclosed as of the end of September.

Page 1 of 2
Loading Comments...